| Literature DB >> 25483426 |
Michael R Fettiplace1, Kinga Lis1, Richard Ripper1, Katarzyna Kowal1, Adrian Pichurko1, Dominic Vitello2, Israel Rubinstein3, David Schwartz2, Belinda S Akpa4, Guy Weinberg5.
Abstract
Triglyceride micro-emulsions such as Intralipid® have been used to reverse cardiac toxicity induced by a number of drugs but reservations about their broad-spectrum applicability remain because of the poorly understood mechanism of action. Herein we report an integrated mechanism of reversal of bupivacaine toxicity that includes both transient drug scavenging and a cardiotonic effect that couple to accelerate movement of the toxin away from sites of toxicity. We thus propose a multi-modal therapeutic paradigm for colloidal bio-detoxification whereby a micro-emulsion both improves cardiac output and rapidly ferries the drug away from organs subject to toxicity. In vivo and in silico models of toxicity were combined to test the contribution of individual mechanisms and reveal the multi-modal role played by the cardiotonic and scavenging actions of the triglyceride suspension. These results suggest a method to predict which drug toxicities are most amenable to treatment and inform the design of next-generation therapeutics for drug overdose. Published by Elsevier B.V.Entities:
Keywords: Antidote; Biodetoxification; Bupivacaine; Lipid emulsion; Local anesthetic; Triglyceride
Mesh:
Substances:
Year: 2014 PMID: 25483426 PMCID: PMC4293282 DOI: 10.1016/j.jconrel.2014.11.018
Source DB: PubMed Journal: J Control Release ISSN: 0168-3659 Impact factor: 9.776